ORCHIECTOMY AND ORCHIECTOMY PLUS MITOMYCIN C FOR METASTATIC PROSTATE CANCER IN PATIENTS WITH POOR PROGNOSIS: THE FINAL RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH IN CANCER THERAPY GENITOURINARY GROUP TRIAL-Reference-Cited by-同舟云学术

ORCHIECTOMY AND ORCHIECTOMY PLUS MITOMYCIN C FOR METASTATIC PROSTATE CANCER IN PATIENTS WITH POOR PROGNOSIS: THE FINAL RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH IN CANCER THERAPY GENITOURINARY GROUP TRIAL

Published:1999-11 Issue:5 Volume:162 Page:1658-1665
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

de Reijke THEO M.¹,Keuppens Frans I.¹,Whelan Peter¹,Kliment Jan¹,Robinson Mel R.G.¹,Rea Lesley-Ann¹,Sylvester Richard J.¹,

Affiliation:

1. From the Academic Medical Center, Amsterdam, The Netherlands

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference28 articles.

1. Advanced prostatic carcinoma. Early versus late endocrine therapy;Kozlowski;Urol. Clin. N. Amer.,1991

2. Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of cancer trials;de Voogt;J. Urol.,1989

3. Prostate Cancer Trialists’ Collaborative Group;Lancet,1995

4. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning 3327-H adenocarcinoma;Isaacs;Cancer Res.,1981

5. Intermittent androgen suppression in the treatment of prostate cancer: A preliminary report;Goldenberg;Urology,1995

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer;Journal of Clinical Oncology;2024-03-20

2. Chemotherapy in hormono-naïve prostate cancer;Revisiones en Cáncer;2024

3. Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?;Clinical Genitourinary Cancer;2023-08

4. Combinations of Hormonal Therapy and Chemotherapy;Bone Metastases from Prostate Cancer;2016-11-08

5. Chemotherapy for metastatic castrate-sensitive prostate cancer;Prostate Cancer and Prostatic Diseases;2016-03-15